This is the first study, to our knowledge, to show transcriptome data using RNA-Seq based on TIM-3 expression in RCC patients with high PD-1 expression although there was a recently published study on transcriptome data based on the intensity of PD-1 in non-small lung cancer patients3. This evidence concerns the gene HAVCR2 and renal cell carcinoma.